CVE-2025-15066

CVE-2025-15066 is a medium-severity vulnerability with a CVSS 3.x base score of 6.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Missing Authorization vulnerability in Innorix WP allows Path Traversal.This issue affects Innorix WP from All versions If the "exam" directory exists under the directory where the product is installed (ex: innorix/exam)

Frequently asked questions

What is CVE-2025-15066?
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Missing Authorization vulnerability in Innorix WP allows Path Traversal.This issue affects Innorix WP from All versions If the "exam" directory exists under the directory where the product is installed (ex: innorix/exam)
How severe is CVE-2025-15066?
CVE-2025-15066 has a CVSS 3.x base score of 6.2, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2025-15066 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (4th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-15066?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-15066 have an EU (EUVD) identifier?
Yes. CVE-2025-15066 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-205542.
When was CVE-2025-15066 published?
CVE-2025-15066 was published on 2025-12-29 and last updated on 2026-06-17.

References

Other CWE-22 (Path Traversal) vulnerabilities

Browse all CWE-22 (Path Traversal) vulnerabilities →